1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. REMUS PHARMACEUTICALS LTD.
Remus Pharmaceuticals Ltd. NSE: REMUS
734.70 -34.20 (-4.45%)
9,900

NSE 05 Jan, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert



Board Meetings - Remus Pharma

The latest board meeting for Remus Pharma took place on 10 Nov 2025, for the purpose of Quarterly Results & Interim Dividend

Ex-date Purpose Notes
10 Nov 2025 Quarterly Results & Interim Dividend -
17 May 2025 Audited Results, Dividend & Others To consider 1. Bonus 2. Other business matters.
09 Nov 2024 Quarterly Results & Interim Dividend To consider other business matters.
16 May 2024 Audited Results -
23 Apr 2024 Bonus issue & Interim Dividend -
22 Apr 2024 Interim Dividend -